2161. Screening for gestational diabetes mellitus: U.S. Preventive Services Task Force recommendation statement.
Update of the 2008 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for gestational diabetes mellitus (GDM).
2169. Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.
作者: Harry J de Koning.;Rafael Meza.;Sylvia K Plevritis.;Kevin ten Haaf.;Vidit N Munshi.;Jihyoun Jeon.;Saadet Ayca Erdogan.;Chung Yin Kong.;Summer S Han.;Joost van Rosmalen.;Sung Eun Choi.;Paul F Pinsky.;Amy Berrington de Gonzalez.;Christine D Berg.;William C Black.;Martin C Tammemägi.;William D Hazelton.;Eric J Feuer.;Pamela M McMahon.
来源: Ann Intern Med. 2014年160卷5期311-20页
The optimum screening policy for lung cancer is unknown.
2171. Screening for lung cancer: U.S. Preventive Services Task Force recommendation statement.
Update of the 2004 U.S. Preventive Services Task Force (USPSTF) recommendation on screening for lung cancer.
2173. Health policy basics: Medicaid expansion.
Medicaid is the largest single source of health insurance coverage in the United States, providing insurance for more than 62 million persons and families in 2013. The Patient Protection and Affordable Care Act sought to expand Medicaid eligibility to nearly all low-income persons with incomes up to 138% of the federal poverty level. However, the U.S. Supreme Court ruled that states' expansion would be optional. Although more than half of the states and the District of Columbia have opted to expand Medicaid starting in 2014, many states continue to oppose increasing access to the program. This article will discuss the basic provisions of the expansion and the benefits and challenges patients and physicians may face as Medicaid grows.
2174. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: a systematic review to update the U.S. Preventive Services Task Force recommendation.
作者: Heidi D Nelson.;Miranda Pappas.;Bernadette Zakher.;Jennifer Priest Mitchell.;Leila Okinaka-Hu.;Rongwei Fu.
来源: Ann Intern Med. 2014年160卷4期255-66页
Mutations in breast cancer susceptibility genes (BRCA1 and BRCA2) are associated with increased risks for breast, ovarian, and other types of cancer.
2176. Risk assessment, genetic counseling, and genetic testing for BRCA-related cancer in women: U.S. Preventive Services Task Force recommendation statement.
Update of the 2005 U.S. Preventive Services Task Force (USPSTF) recommendation on genetic risk assessment and BRCA mutation testing for breast and ovarian cancer susceptibility.
|